Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Probe Gold Inc. (TSX: PRB) (OTCQB: PROBF) (“ Probe ” or the “ Company ”) is pleased to announce the appointment of Marc Ducharme as Vice President of Exploration, effective immediately. Mr. Marc...

PURCHASE, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that abstracts summarizing clinical e...

Toronto, Ontario--(Newsfile Corp. - July 2, 2024) - Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) ("Aurania" or the "Company") announces the grant of 2,154,000 stock options to directors, officers, employees and consultants pursuant to the terms and subject to the conditions of t...

PSEG To Announce Second Quarter 2024 Financial Results On July 30 PR Newswire NEWARK, N.J. , July 2, 2024 /PRNewswire/ -- Public Service Enterprise Group Incorporated (PSEG) will host its second quarter 2024 earnings call at 11:00 a.m. ET on Tuesday , July 3...

Vancouver, British Columbia--(Newsfile Corp. - July 2, 2024) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) (" Kenorland " or the " Company ") is pleased to announce the engagement of BBA Consultants (" BBA "), an engineering consulting firm, in preparation for a potential aut...

CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study PR Newswire CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S....

NYSE: HUM Lawsuit Alert: Investors who lost money with shares of Humana Inc. should contact the Shareholders Foundation PR Newswire SAN DIEGO , July 2, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors...

ATI Announces Webcast for Second Quarter 2024 Results PR Newswire DALLAS , July 2, 2024 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its second quarter 2024 earnings conference call on Tuesday, August 6 , 2024, at 7:30 a.m...

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be hosting one-on-one meetings with institutional investors at the Leerink Partners Therape...